TCL Archive Phase III Custirsen/Docetaxel/Prednisone Trial Fails Primary Endpoint of Overall Survival April 25, 2014
TCL Archive On “Day One Of Post-Genome World,” Eric Lander Recounts 15-Year Journey. February 16, 2001
TCL Archive ACS Plans To Award 10 New Institutional Grants For Up to $200,000 A Year In Cause And Prevention November 16, 1979